Almirall has completed the decentralised European regulatory procedure for efinaconazole, a triazole antifungal substance ...

Almirall has completed the decentralized EU regulatory procedure for efinaconazole (Jublia) for onychomycosis. The final step ...

Almirall announces completion of decentralized regulatory approval procedure for efinaconazole in Europe ·       Efinaconazole is a triazole antifungal compound indicated for the treatment of ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

Spanish drugmaker Almirall has lined up its new CEO following the departure of Peter Guenter, who left to lead Merck KGaA’s healthcare unit earlier this month ...

The Will Be Dust is Marques-Marcet’s fourth film following his 2014 debut 10,000KM, Anchor & Hope (2017) and The Days To Come ...

Almirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands from US-based Allergan for up to $650 million in cash.

The Business Research Company's Actinic Keratosis Treatment Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The actinic keratosis treatment market size is expected to ...

The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...

Johnson & Johnson (NYSE: JNJ) has reported revenue of $22.5 billion for the third quarter of 2024, a 5.2% increase ...